Huber Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.4M Buy
975,818
+20,300
+2% +$540K 4.23% 6
2025
Q4
$23.8M Buy
955,518
+142,000
+17% +$3.58M 3.5% 8
2025
Q3
$20.7M Buy
813,518
+45,000
+6% +$1.11M 3.28% 7
2025
Q2
$18.6M Buy
768,518
+195,230
+34% +$4.55M 3.17% 12
2025
Q1
$14.5M Buy
573,288
+85,000
+17% +$2.22M 2.74% 11
2024
Q4
$13M Buy
488,288
+286,842
+142% +$7.78M 2.58% 13
2024
Q3
$5.83M Buy
201,446
+50,000
+33% +$1.46M 1.17% 29
2024
Q2
$4.24M Buy
151,446
+118,100
+354% +$3.25M 0.96% 33
2024
Q1
$925K Hold
33,346
0.21% 79
2023
Q4
$960K Sell
33,346
-82,284
-71% -$2.49M 0.24% 74
2023
Q3
$3.84M Sell
115,630
-4,287
-4% -$152K 0.9% 34
2023
Q2
$4.4M Buy
119,917
+2,025
+2% +$78.8K 1.06% 30
2023
Q1
$4.81M Buy
117,892
+38,364
+48% +$1.66M 1.19% 28
2022
Q4
$4.08M Buy
79,528
+8,500
+12% +$408K 1.03% 32
2022
Q3
$3.11M Hold
71,028
0.87% 36
2022
Q2
$3.72M Hold
71,028
1.04% 29
2022
Q1
$3.68M Hold
71,028
0.91% 35
2021
Q4
$4.19M Sell
71,028
-24,302
-25% -$1.2M 1.1% 32
2021
Q3
$4.1M Hold
95,330
1.06% 35
2021
Q2
$3.73M Buy
95,330
+4,500
+5% +$175K 0.95% 36
2021
Q1
$3.29M Buy
90,830
+43,500
+92% +$1.54M 0.89% 34
2020
Q4
$1.74M Sell
47,330
-10,745
-19% -$394K 0.57% 48
2020
Q3
$2.02M Sell
58,075
-102,871
-64% -$3.61M 0.75% 38
2020
Q2
$4.99M Sell
160,946
-4,216
-3% -$143K 1.02% 33
2020
Q1
$5.12M Hold
165,162
0.94% 33
2019
Q4
$6.14M Sell
165,162
-54,597
-25% -$1.94M 0.81% 39
2019
Q3
$7.49M Sell
219,759
-53,859
-20% -$1.96M 0.93% 36
2019
Q2
$11.2M Sell
273,618
-38,155
-12% -$1.52M 1.34% 27
2019
Q1
$12.6M Sell
311,773
-37,101
-11% -$1.49M 1.33% 29
2018
Q4
$14.4M Sell
348,874
-164,002
-32% -$6.81M 1.32% 32
2018
Q3
$21.4M Sell
512,876
-104,768
-17% -$4.03M 1.39% 25
2018
Q2
$21.3M Sell
617,644
-174,289
-22% -$5.96M 1.38% 27
2018
Q1
$26.7M Sell
791,933
-240,945
-23% -$8.28M 1.56% 20
2017
Q4
$35.5M Sell
1,032,878
-36,995
-3% -$1.26M 1.93% 14
2017
Q3
$36.2M Sell
1,069,873
-225,135
-17% -$7.24M 1.99% 14
2017
Q2
$41.3M Sell
1,295,008
-19,709
-1% -$622K 2.11% 13
2017
Q1
$42.7M Sell
1,314,717
-50,382
-4% -$1.59M 2.2% 12
2016
Q4
$42.1M Sell
1,365,099
-132,698
-9% -$4.05M 1.62% 23
2016
Q3
$48.1M Sell
1,497,797
-111,197
-7% -$3.72M 1.9% 17
2016
Q2
$53.8M Sell
1,608,994
-216,808
-12% -$6.92M 2.21% 12
2016
Q1
$51.3M Sell
1,825,802
-4,532
-0.2% -$129K 2.06% 12
2015
Q4
$56.1M Sell
1,830,334
-27,299
-1% -$859K 1.99% 15
2015
Q3
$55.4M Sell
1,857,633
-301,138
-14% -$9.66M 1.94% 16
2015
Q2
$68.7M Sell
2,158,771
-456,108
-17% -$14.9M 2% 14
2015
Q1
$86.3M Sell
2,614,879
-111,619
-4% -$3.55M 2.71% 5
2014
Q4
$80.6M Sell
2,726,498
-22,302
-0.8% -$639K 2.49% 8
2014
Q3
$77.1M Sell
2,748,800
-281,445
-9% -$7.9M 2.24% 12
2014
Q2
$85.3M Buy
3,030,245
+33,939
+1% +$967K 2.19% 11
2014
Q1
$91.3M Buy
2,996,306
+71,250
+2% +$2.12M 2.4% 6
2013
Q4
$85M Buy
2,925,056
+545,762
+23% +$15.9M 2.33% 7
2013
Q3
$64.8M Buy
2,379,294
+37,311
+2% +$1.02M 2.25% 7
2013
Q2
$62.2M Buy
+2,341,983
New +$64.7M 2.48% 5

Other funds holding PFE

Huber Capital Management's PFE Position: Q1 2026 in Review

Huber Capital Management increased its Pfizer (PFE) stake by 2.1% in Q1 2026, buying an estimated $540K and bringing the position to 975,818 shares worth $27.4M. The position accounts for 4.23% of the portfolio, ranked #6.

Huber Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $91.3M in Q1 2014. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Huber Capital Management held 975,818 shares of Pfizer worth $27.4M as of Q1 2026.
  • Huber Capital Management bought 20,300 Pfizer shares in Q1 2026, an estimated $540K.
  • Pfizer made up 4.23% of Huber Capital Management's portfolio in Q1 2026, its #6 holding.
  • Huber Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Huber Capital Management's Pfizer position peaked at $91.3M in Q1 2014.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Huber Capital Management's 13F filing for Q1 2026, filed 12 May 2026.